CD34+ dermal dendritic cells and mucin deposition in dermatomyositis

doi:10.5314/wjd.v5.i2.65

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6982)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

483

WORD

302

HTML

3606

Figures (1-4)

257

Tables (1-3)

270

Sum=4918

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

800

Download

1264

Sum=2064

May 2, 2016 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Diagnostic Advances

World J Dermatol. May 2, 2016; 5(2): 65-71
Published online May 2, 2016. doi: 10.5314/wjd.v5.i2.65

Full Size Figure Download Figure

Figure 4 Proposed pathogenic mechanism underlying dermal mucin deposition in dermatomyositis. α-SMA: α-smooth muscle actin; N: Nucleus; TSHR: Thyroid-stimulating hormone receptor; HAS: Hyaluronan synthase.

Citation: Yokoyama E, Nakamura Y, Okita T, Nagai N, Muto M. CD34+ dermal dendritic cells and mucin deposition in dermatomyositis. World J Dermatol 2016; 5(2): 65-71
URL: https://www.wjgnet.com/2218-6190/full/v5/i2/65.htm
DOI: https://dx.doi.org/10.5314/wjd.v5.i2.65